Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 23, 2015

View Archived Issues

BTZ-169 active in tuberculosis model, phase I study planned

Models reveal role of epoxyeicosatrienoic acids in hematopoietic stem and progenitor cell transplant

Deciphera closes Series B financing

Corbus starts enrolling adults with CF into phase II trial of Resunab

SOFIA transgenic pig enables study of insulin secretory granule processing

Clinical outcomes reported for triheptanoin in rare metabolic disorders

Armetheon and Lee's Pharma to develop tecarfarin in China and Thailand

European Commission approves Zalviso for acute moderate to severe postoperative pain

H3 Biomedicine and Selvita prolong collaboration for cancer medicines

AB Science stops phase III study of masitinib in rheumatoid arthritis

Intra-Cellular Therapies announces end of phase I for ITI-214 and initiates public share offer

International Progressive MS Alliance grants planning awards to advance efforts in progressive MS

AbbVie reports 5-HT2C receptor agonists

Kallikrein inhibitors described in BioCryst Pharmaceuticals patent

Nagoya City University divulges antimalaria agents

Bristol-Myers Squibb patents MGAT2 inhibitors

GlaxoSmithKline introduces EZH2 inhibitors

Antibacterial compounds in early development at Actelion Pharmaceuticals

Susan G. Komen announces new grants for breast cancer research

FDA approves Lonsurf for refractory metastatic colorectal cancer

KCNJ10 gene polymorphism identified in childhood epilepsy

Phase I trial explores HPV-16/18 E6/E7-specific T lymphocytes in patients with relapsed HPV cancers

In vitro and in vivo activity of BPI-7711 against EGFR-mutated NSCLC

ZP-I-98: a novel GIP receptor agonist

Promising topline results from phase II study of HTX-011 for postoperative pain

RuiYi initiates first human dosing of gerilimzumab

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...